Brooklyn ImmunoTherapeutics (NYSE:BTX) Receives New Coverage from Analysts at StockNews.com
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report report published on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Brooklyn ImmunoTherapeutics stock opened at $1.89 on Friday. The company has a market capitalization of $111.18 million, a price-to-earnings ratio of -0.83 […]
More Stories
Head to Head Analysis: Iota Communications (OTCMKTS:IOTC) and Cass Information Systems (NASDAQ:CASS)
Cass Information Systems (NASDAQ:CASS – Get Free Report) and Iota Communications (OTCMKTS:IOTC – Get Free Report) are both computer and...
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Declines By 12.3%
AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) was the recipient of a significant decrease in short interest during the month...
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Sees Large Increase in Short Interest
ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) was the recipient of a large increase in short interest during...
X-Links Crude Oil Shares Covered Call ETN (NASDAQ:USOI) Short Interest Down 19.5% in December
X-Links Crude Oil Shares Covered Call ETN (NASDAQ:USOI – Get Free Report) was the target of a significant drop in...
Short Interest in Ultralife Co. (NASDAQ:ULBI) Grows By 19.3%
Ultralife Co. (NASDAQ:ULBI – Get Free Report) was the recipient of a large increase in short interest in December. As...
Tyra Biosciences, Inc. (NASDAQ:TYRA) Short Interest Up 25.9% in December
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) saw a significant increase in short interest in the month of December....